SUNATION ENERGY Amends Suniva Merger, Sets Equity Value at $14.7M
The amendment pegs SUNation's equity value at $14,719,624 plus debt conversions and new financing, and converts up to $2.6 million of parent debt at $2.26 a share.
The amendment pegs SUNation's equity value at $14,719,624 plus debt conversions and new financing, and converts up to $2.6 million of parent debt at $2.26 a share.
Tadaa Technology will supply the AI backbone for a 1,000-acre solar farm feeding a data centre under a 25-year power arrangement, targeting $7.3M in annual revenue.
Alpha Compute has signed definitive agreements for Utica and Marcellus acreage with more than 75 wells, and plans to build a data center on the site.
Palisade Bio can start the Phase 2 ASCENTRA-CD trial of its oral PDE4 prodrug, with first dosing targeted for Q1 2027 and a primary readout in Q1 2028.
VERSATILE-002 results for PDS0101 plus pembrolizumab show 39.3 months median overall survival in checkpoint-inhibitor-naive HPV16-positive head and neck cancer.